Cynthia is an accomplished executive director and chief compliance officer with over 17 years of experience providing first-to-market solutions to the challenges sponsor face whilst using risk management strategies to mitigate ones in the future. She is an industry expert with contributions to over 450 sponsor programs with a proven track record of optimization, quality, compliance, and fiscal responsibility. Cynthia is a certified Quality Assurance (QA) and Regulatory Affairs (RA) executive, principal consultant, and published biotechnologist with an emphasis in fabricating quality-based process and product development strategies in regulated pharmaceutical, medical device, and biopharma industries. In her tenure, she has led strategic partnerships to solve the complexities of the life science industry by providing tailored expertise with the time and resources necessary to mitigate the challenge's sponsors face with expertly sourced solutions. She drives QBD initiatives into corporate portfolios to which traverse all phases of development and deployment from a financial, operative, quality, and regulatory vantage. As an expert in national and international GxP regulations, standards, and guidance's, her expertise has been engaged as an international HA consultant for over 7yrs with the support that traverses all product development phases to deploy best in class programs for industry sponsors including but not limited to, Gilead, Daichi-Sankyo, Bristol Myers Squib, Amgen, Abbott, Novartis, and Roche.